Cargando…
Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study
BACKGROUND: People with leprosy who have been declared Release From Treatment (RFT) are often not aware of the leprosy sequelae possibility which can decrease their quality of life. This could be because they have been adapting for a long time hence they do not feel the need to see physicians. This...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546734/ https://www.ncbi.nlm.nih.gov/pubmed/37784121 http://dx.doi.org/10.1186/s12886-023-03146-2 |
_version_ | 1785114922098622464 |
---|---|
author | Irawati, Yunia Andayani, Gitalisa Rahayu, Tri Zakiyah, Hindun Kurniawardhani, Dewinta Retno Paramita, Carennia Bani, Anna Puspitasari Daniel, Hisar Susiyanti, Made Lestari, Yeni Dwi Friska, Dewi Menaldi, Sri Linuwih Harini, Melinda |
author_facet | Irawati, Yunia Andayani, Gitalisa Rahayu, Tri Zakiyah, Hindun Kurniawardhani, Dewinta Retno Paramita, Carennia Bani, Anna Puspitasari Daniel, Hisar Susiyanti, Made Lestari, Yeni Dwi Friska, Dewi Menaldi, Sri Linuwih Harini, Melinda |
author_sort | Irawati, Yunia |
collection | PubMed |
description | BACKGROUND: People with leprosy who have been declared Release From Treatment (RFT) are often not aware of the leprosy sequelae possibility which can decrease their quality of life. This could be because they have been adapting for a long time hence they do not feel the need to see physicians. This study seeks to compare the results of Vision-Related Quality of Life (VR-QoL) among RFT persons based on the National Eye Institute Visual Functioning Questionnaire–25 (NEI-VFQ-25) and WHO grading disability based on physical examination. METHODS: A cross-sectional study of 325 RFT subjects from leprosy communities (Singkawang, West Kalimantan and Tangerang, Banten) was conducted between 2018 and 2019. We used the NEI-VFQ-25 questionnaire that had been validated and translated into Indonesian and distributed to the leprosy population. Relationships and comparisons among variables were evaluated using Kruskal–Wallis and Mann–Whitney tests. RESULTS: There were three main results: The median composite score of VR-QoL for WHO grade 0, 1, and 2 disabilities has decreased by 13%, 25.5%, and 30% of the maximum value, respectively. Of the total, eleven subscales were statistically significant between WHO grading disability and VR-QoL based on the NEI-VFQ-25 (p < 0.05). The comparison between grade 0 and grade 2 disability in all subscales was statistically significant (p < 0.05). CONCLUSIONS: The grade of disability is related to their VR-QoL assessment using the NEI-VFQ-25 questionnaire. Thus, it can be used as an initial screening in primary healthcare settings to increase awareness of disability before a thorough physical examination. |
format | Online Article Text |
id | pubmed-10546734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105467342023-10-04 Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study Irawati, Yunia Andayani, Gitalisa Rahayu, Tri Zakiyah, Hindun Kurniawardhani, Dewinta Retno Paramita, Carennia Bani, Anna Puspitasari Daniel, Hisar Susiyanti, Made Lestari, Yeni Dwi Friska, Dewi Menaldi, Sri Linuwih Harini, Melinda BMC Ophthalmol Research BACKGROUND: People with leprosy who have been declared Release From Treatment (RFT) are often not aware of the leprosy sequelae possibility which can decrease their quality of life. This could be because they have been adapting for a long time hence they do not feel the need to see physicians. This study seeks to compare the results of Vision-Related Quality of Life (VR-QoL) among RFT persons based on the National Eye Institute Visual Functioning Questionnaire–25 (NEI-VFQ-25) and WHO grading disability based on physical examination. METHODS: A cross-sectional study of 325 RFT subjects from leprosy communities (Singkawang, West Kalimantan and Tangerang, Banten) was conducted between 2018 and 2019. We used the NEI-VFQ-25 questionnaire that had been validated and translated into Indonesian and distributed to the leprosy population. Relationships and comparisons among variables were evaluated using Kruskal–Wallis and Mann–Whitney tests. RESULTS: There were three main results: The median composite score of VR-QoL for WHO grade 0, 1, and 2 disabilities has decreased by 13%, 25.5%, and 30% of the maximum value, respectively. Of the total, eleven subscales were statistically significant between WHO grading disability and VR-QoL based on the NEI-VFQ-25 (p < 0.05). The comparison between grade 0 and grade 2 disability in all subscales was statistically significant (p < 0.05). CONCLUSIONS: The grade of disability is related to their VR-QoL assessment using the NEI-VFQ-25 questionnaire. Thus, it can be used as an initial screening in primary healthcare settings to increase awareness of disability before a thorough physical examination. BioMed Central 2023-10-02 /pmc/articles/PMC10546734/ /pubmed/37784121 http://dx.doi.org/10.1186/s12886-023-03146-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Irawati, Yunia Andayani, Gitalisa Rahayu, Tri Zakiyah, Hindun Kurniawardhani, Dewinta Retno Paramita, Carennia Bani, Anna Puspitasari Daniel, Hisar Susiyanti, Made Lestari, Yeni Dwi Friska, Dewi Menaldi, Sri Linuwih Harini, Melinda Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title | Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title_full | Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title_fullStr | Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title_full_unstemmed | Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title_short | Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study |
title_sort | vision-related quality of life among released from treatment cases of leprosy evaluated with nei-vfq-25: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546734/ https://www.ncbi.nlm.nih.gov/pubmed/37784121 http://dx.doi.org/10.1186/s12886-023-03146-2 |
work_keys_str_mv | AT irawatiyunia visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT andayanigitalisa visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT rahayutri visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT zakiyahhindun visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT kurniawardhanidewintaretno visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT paramitacarennia visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT baniannapuspitasari visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT danielhisar visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT susiyantimade visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT lestariyenidwi visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT friskadewi visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT menaldisrilinuwih visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy AT harinimelinda visionrelatedqualityoflifeamongreleasedfromtreatmentcasesofleprosyevaluatedwithneivfq25acrosssectionalstudy |